Effects of telmisartan on nitric oxide synthase inhibition in patients with insulin resistance syndrome

Trial Profile

Effects of telmisartan on nitric oxide synthase inhibition in patients with insulin resistance syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jan 2011

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Atherosclerosis; Insulin resistance
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top